← Open Payments lookup

KIMBERLY ATWOOD: Open Payments

NPI 1700161593 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$569 in 27 payments from 13 companies in 2025. Trend: 2023 $439 · 2024 $663 · 2025 $569

Food & beverage: $569
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation6$112
Calliditas Therapeutics US Inc.3$81
Travere Therapeutics, Inc.5$73
GlaxoSmithKline, LLC.2$47
Fresenius USA Marketing, Inc.2$44
Bayer Healthcare Pharmaceuticals Inc.2$43
Cycle Pharmaceuticals Inc1$34
Otsuka America Pharmaceutical, Inc.1$30
Ardelyx, Inc.1$25
AstraZeneca Pharmaceuticals LP1$23

Products named: TARPEYO, BENLYSTA, VELPHORO, Kerendia, Vanrafia, Venxxiva, JYNARQUE, IBSRELA.

Industry payments across NC — which companies pay providers there.